脑植入市场 - 全球产业规模、份额、趋势、机会及预测（按产品类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球脑植入市场预计将从 2025 年的 69.8 亿美元成长到 2031 年的 127.7 亿美元，复合年增长率达到 10.59%。

这些医疗设备植入颅腔内，透过刺激神经通路或记录电活动，直接与生物神经系统相互作用，进而治疗神经系统疾病。推动该市场成长要素包括帕金森氏症、癫痫和忧郁症严重的日益增多，以及全球人口老化导致长期照护需求增加。世界卫生组织的数据显示，到2024年，全球将有超过30亿人受到神经系统疾病的影响，使其成为疾病和残疾的主要原因之一。

然而，由于所需手术高成本且具侵入性，该市场面临许多障碍。这些相关风险往往会阻碍患者接受治疗，并增加新设备监管核准流程的复杂性。此外，不同医疗体系严格的报销政策也造成了经济障碍，限制了这些治疗技术的广泛应用，最终减缓了该行业在全球范围内的发展。

市场驱动因素

神经技术和脑机介面（BCI）领域资本投资的显着成长正在改变市场格局，为加速临床试验和扩大生产规模提供了所需的流动性。企业和创业投资的涌入使各公司能够在遵守III类医疗设备高昂且复杂的监管要求的同时，推动硬体耐用性和讯号处理技术的快速创新。例如，2025年5月，Semafor报道称，Neuralink完成了资金筹措，估值约为90亿美元，显示投资者对植入式神经技术的可扩展性充满信心。这种资金动能与临床进展相辅相成。 2025年10月，Fierce Biotech发表的研究结果显示，Science Corp.的PRIMA BCI视网膜植入成功恢復了重度老龄化黄斑部病变患者的部分视力，进一步证实了该领域的治疗潜力。

同时，微创神经外科手术需求的不断增长，透过降低传统开放性手术的风险和缩短恢復时间，扩大了患者群体。患者和医疗服务提供者都倾向于选择血管内和微创植入技术，这些技术可以减少感染和脑组织损伤等手术併发症，并提高其应用率。这种转变正在推动策略性商业化进程。根据 MedTech Dive 2025 年 11 月的报告，Synchron 公司在 D 轮资金筹措中筹集了 2 亿美元，为其 Stentrode 系统的上市做准备。本系统无需开颅即可经颈静脉植入。此类输送机制的进步对于将脑植入从实验性治疗转变为治疗瘫痪和其他神经系统疾病的实用、普及的医疗解决方案至关重要。

市场挑战

全球脑植入市场受到高成本和手术创伤性等诸多因素的显着限制。脑植入通常需要复杂的脑外科手术，例如开颅手术，并伴随感染疾病、出血和中风等重大健康风险。这些风险，加上植入设备高昂的费用和术后长期照护的需求，构成了很高的进入门槛。因此，患者和医疗机构通常仅在药物治疗无效的严重病例中才考虑此类手术，从而缩小了潜在市场。

目前的应用统计数据表明，这种限制显而易见。根据美国神经外科医师协会统计，截至2024年，全球已有超过16万名患者接受了深部脑部刺激术治疗各种神经系统疾病。然而，考虑到数百万患有运动障碍的患者，这项应用率仍然非常低。大量符合资格的患者与有限的医疗服务提供者之间存在着鲜明的对比，这凸显了经济和程序方面的挑战如何有效地阻碍了该领域的广泛发展。

市场趋势

直接神经控制技术在言语和运动功能恢復方面的出现，正从根本上改变市场格局，使义肢从简单的游标控制发展到能够快速、自然地进行交流。这一趋势的驱动力在于复杂的演算法，这些演算法能够将神经活动转化为流畅的语言，其速度和准确性堪比自然对话，从而克服了前几代产品存在的显着延迟问题。近期一项重要的成果便是对这项技术的展示：根据美联社2025年4月发表的题为《中风倖存者藉助实验性脑植入再次开口说话》的报导，一种新型脑机接口系统成功地将一位瘫痪的中风倖存者的神经信号转化为语音，其速度约为每分钟91个单词，显着超越了以往的标准。

同时，封闭回路型自适应深部脑部刺激系统的引入，正透过从静态、连续刺激转向动态、响应式治疗，重新定义运动障碍的治疗标准。这些新一代植入采用整合感测技术，监测局部场电位，并即时自动调节电刺激，从而优化临床疗效，同时最大限度地减少有害副作用。这种向个人化生物电子医学的转变已取得重要的商业性里程碑。根据 MedTech Dive 2025 年 2 月发表的报导《美敦力公司用于帕金森氏症的自适应 DBS 系统获得 FDA核准》，Medtronic的 BrainSense 自适应 DBS 设备已获得 FDA核准，成为首个基于检测到的脑活动而获得监管部门批准的自适应治疗系统。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球脑植入市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（深部脑部刺激器、脊髓刺激设备、迷走神经刺激设备）
  • 根据适应症（慢性疼痛、癫痫、帕金森氏症、忧郁症、自发性震颤、阿兹海默症）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美脑植入市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲脑植入市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区脑植入市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲脑植入市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲脑植入市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球脑植入市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• NeuroPace, Inc.
• LivaNova plc
• Aleva Neurotherapeutics SA
• Neuralink Corporation
• Synchron, Inc.
• Paradromics Inc.
• Blackrock Neurotech

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Brain Implants Market is projected to expand from USD 6.98 Billion in 2025 to USD 12.77 Billion by 2031, achieving a CAGR of 10.59%. These medical devices are implanted within the cranial cavity to interact directly with the biological nervous system, either by stimulating neural pathways or recording electrical activity to treat neurological disorders. The market is primarily driven by the increasing prevalence of debilitating conditions like Parkinson's disease, epilepsy, and depression, as well as an aging global population that needs long-term care. Data from the World Health Organization indicates that in 2024, neurological conditions affected more than 3 billion people worldwide, making them the leading cause of illness and disability globally.

However, the market confronts substantial hurdles due to the high cost and invasive nature of the required surgical procedures. These associated risks frequently discourage patient adoption and add complexity to the regulatory approval process for new devices. Additionally, strict reimbursement policies across various healthcare systems establish financial barriers that limit widespread access to these therapeutic technologies, effectively slowing the overall growth of the global sector.

Market Driver

A significant surge in capital investment within neurotechnology and brain-computer interfaces (BCI) is transforming the market, providing the liquidity needed to accelerate clinical trials and scale manufacturing. This influx of corporate funding and venture capital enables companies to navigate the expensive and complex regulatory requirements for Class III medical devices while driving rapid innovation in hardware durability and signal processing. For example, Semafor reported in May 2025 that Neuralink secured $600 million in a funding round that valued the company at roughly $9 billion, indicating strong investor confidence in the scalability of implantable neural technologies. This financial momentum is matched by clinical progress; Fierce Biotech noted in October 2025 that a study showed Science Corp.'s PRIMA BCI retinal implant successfully restored partial vision in patients with severe age-related macular degeneration, confirming the sector's therapeutic potential.

Simultaneously, the increasing demand for minimally invasive neurosurgical procedures is broadening the addressable patient population by lowering the risks and recovery times linked to traditional craniotomies. Both patients and providers are showing a preference for endovascular and less traumatic insertion methods, which reduce surgical complications like infection and brain tissue damage, thereby improving adoption rates. This shift is fueling strategic commercialization efforts; according to MedTech Dive in November 2025, Synchron raised $200 million in Series D financing to prepare for the market launch of its Stentrode system, a device designed for implantation via the jugular vein without open-brain surgery. Such advancements in delivery mechanisms are essential for transitioning brain implants from experimental treatments to viable, widespread medical solutions for paralysis and other neurological deficits.

Market Challenge

The Global Brain Implants Market is significantly constrained by the high cost and invasive nature of the required surgical procedures. Brain implants typically necessitate complex neurosurgeries, such as open-skull craniotomies, which carry substantial health risks including infection, hemorrhage, and stroke. These dangers, combined with the prohibitive costs of the implantable devices and the need for long-term post-operative care, create a high barrier to entry. Consequently, patients and healthcare providers often limit these interventions to only the most severe cases where pharmaceutical treatments have failed, thereby reducing the potential addressable market.

This restrictive dynamic is evident in current adoption statistics. According to the American Association of Neurological Surgeons, deep brain stimulation was used to treat over 160,000 people globally for various neurological conditions in 2024. When compared to the millions of patients suffering from debilitating movement disorders, this adoption figure is disproportionately low. The stark contrast between the vast eligible patient population and the limited number of treated individuals highlights how these financial and procedural challenges effectively stifle the broader expansion of the sector.

Market Trends

The Emergence of Speech and Motor Restoration via Direct Neural Control is fundamentally reshaping the market landscape by evolving neuroprosthetics from basic cursor control to the reconstruction of rapid, naturalistic communication. This trend is driven by advanced algorithms that can decode neural activity into fluent speech with a speed and accuracy that rivals natural conversation, overcoming the significant latency issues found in earlier generations. A major validation of this capability was reported recently; according to The Associated Press in April 2025, in an article titled 'A stroke survivor speaks again with the help of an experimental brain-computer implant,' a new brain-computer interface system successfully decoded the neural signals of a paralyzed stroke survivor into speech at a rate of approximately 91 words per minute, significantly surpassing previous standards.

In parallel, the Adoption of Closed-Loop Adaptive Deep Brain Stimulation Systems is redefining the standard of care for movement disorders by replacing static, continuous stimulation with dynamic, responsive therapy. These next-generation implants employ integrated sensing technology to monitor local field potentials and automatically modulate electrical delivery in real-time, thereby optimizing clinical efficacy while minimizing adverse side effects. This shift toward personalized bio-electronic medicine reached a critical commercial milestone; according to MedTech Dive in February 2025, in the article 'Medtronic gains FDA OK for self-adjusting DBS system for Parkinson's,' Medtronic received FDA approval for its BrainSense Adaptive DBS device, marking the first regulatory authorization for a system that self-adjusts therapy based on detected brain activity.

Key Market Players

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• NeuroPace, Inc.
• LivaNova plc
• Aleva Neurotherapeutics SA
• Neuralink Corporation
• Synchron, Inc.
• Paradromics Inc.
• Blackrock Neurotech

Report Scope

In this report, the Global Brain Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brain Implants Market, By Product Type

• Deep Brain Stimulators
• Spinal Cord Stimulators
• Vagus Nerve Stimulators

Brain Implants Market, By Application

• Chronic Pain
• Epilepsy
• Parkinson's Disease
• Depression
• Essential Tremor
• Alzheimer's Disease

Brain Implants Market, By End User

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Brain Implants Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Brain Implants Market.

Available Customizations:

Global Brain Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brain Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators)
  • 5.2.2. By Application (Chronic Pain, Epilepsy, Parkinson's Disease, Depression, Essential Tremor, Alzheimer's Disease)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Brain Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Brain Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Brain Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Brain Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Brain Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Brain Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Brain Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Brain Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Brain Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Brain Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Brain Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Brain Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Brain Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Brain Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Brain Implants Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Brain Implants Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Brain Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Brain Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Brain Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Brain Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Brain Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Brain Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Brain Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Brain Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Brain Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boston Scientific Corporation
• 15.3. Abbott Laboratories
• 15.4. NeuroPace, Inc.
• 15.5. LivaNova plc
• 15.6. Aleva Neurotherapeutics SA
• 15.7. Neuralink Corporation
• 15.8. Synchron, Inc.
• 15.9. Paradromics Inc.
• 15.10. Blackrock Neurotech

16. Strategic Recommendations

17. About Us & Disclaimer